122 related articles for article (PubMed ID: 5025144)
1. Distigmine bromide (Ubretid) for the prevention of urinary retention after vaginal hysterectomy.
Walsh J; Bonnar J
J Obstet Gynaecol Br Commonw; 1972 Apr; 79(4):377-8. PubMed ID: 5025144
[No Abstract] [Full Text] [Related]
2. A further report on the effect of distigmine bromide (Ubretid) on the neurogenic bladder.
Yeo J; Southwell P; Rutowski S; Marchant-Williams H
Med J Aust; 1974 Aug; 2(6):201-3. PubMed ID: 4424051
[No Abstract] [Full Text] [Related]
3. Preliminary report on the effect of distigmine bromide on the neurogenic bladder.
Yeo J; Southwell P; Hindmarsh E
Med J Aust; 1973 Jan; 1(3):116-20. PubMed ID: 4690345
[No Abstract] [Full Text] [Related]
4. [Studies on the urinary complications following radical hysterectomy for cancer of the cervix].
Yamao T
Nihon Sanka Fujinka Gakkai Zasshi; 1972 Jan; 24(1):31-8. PubMed ID: 5062549
[No Abstract] [Full Text] [Related]
5. Complications of vaginal surgery.
Gray LA
Clin Obstet Gynecol; 1982 Dec; 25(4):869-81. PubMed ID: 7160120
[No Abstract] [Full Text] [Related]
6. [Use of Ubretid in the prevention of urine retention in the bladder following surgery for gynecologic diseases].
Kanadys W; Danelczyk W
Ginekol Pol; 1978 Jun; 49(6):531-3. PubMed ID: 28996
[No Abstract] [Full Text] [Related]
7. Distigmine bromide and post-prostatectomy voiding.
Shah PJ; Abrams PH; Choa RG; Ashken MH; Gaches CG; Green NA; Wiles A
Br J Urol; 1983 Apr; 55(2):229-32. PubMed ID: 6132645
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical review: Ubretid - beta-carotene.
Martin S
Lamp; 1978 Nov; 35(11):37-9. PubMed ID: 32442
[No Abstract] [Full Text] [Related]
9. Distigmine bromide (ubretid) in the prevention of postoperative retention of urine.
Cameron MD
J Obstet Gynaecol Br Commonw; 1966 Oct; 73(5):847-8. PubMed ID: 5331476
[No Abstract] [Full Text] [Related]
10. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
Katsumi T; Murayama K
Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor.
Bougas DA; Mitsogiannis IC; Mitropoulos DN; Kollaitis GC; Serafetinides EN; Giannopoulos AM
Int Urol Nephrol; 2004; 36(4):507-12. PubMed ID: 15787326
[TBL] [Abstract][Full Text] [Related]
12. Distigmine (ubretid).
Drug Ther Bull; 1968 Jul; 6(15):60. PubMed ID: 4875862
[No Abstract] [Full Text] [Related]
13. Cholinergic crisis following treatment of postoperative urinary retention with distigmine bromide.
Hameed A; Charles TJ
Br J Clin Pract; 1994; 48(2):103-4. PubMed ID: 7912951
[TBL] [Abstract][Full Text] [Related]
14. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
Tada M; Fujita N; Umeda M; Koike H; Nagai H
No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
[TBL] [Abstract][Full Text] [Related]
15. Prevention of post-hysterectomy urinary retention by alpha-adrenergic blocker.
Livne PM; Kaplan B; Ovadia Y; Servadio C
Acta Obstet Gynecol Scand; 1983; 62(4):337-40. PubMed ID: 6138916
[TBL] [Abstract][Full Text] [Related]
16. [Acute poisoning due to distigmine bromide].
Onodera M
Chudoku Kenkyu; 2008 Apr; 21(2):161-7. PubMed ID: 18516941
[No Abstract] [Full Text] [Related]
17. Symptomatic and urodynamic improvement by oral distigmine bromide in poor voiders after transurethral resection of the prostate.
Tanaka Y; Masumori N; Itoh N; Furuya S; Nishizawa O; Tsukamoto T
Urology; 2001 Feb; 57(2):270-4. PubMed ID: 11182335
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of acetylcholinesterase by distigmine bromide (Ubretid).
Breuel HP; Bohn-Olszewsky W; Engelsen SJ; Samhaber EM; Niklaus H
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):230-5. PubMed ID: 8100221
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Ubretid eye-drops upon glaucoma].
Mizukawa T; Azuma I
Nihon Ganka Kiyo; 1970 Aug; 21(8):586-95. PubMed ID: 5466336
[No Abstract] [Full Text] [Related]
20. [Activities of true and pseudo cholinesterases in the patients with a partial accommodative esotropia under phospholine iodide and Ubretid treatment (author's transl)].
Kusayama M; Terakado R; Mukuno K; Ishikawa S
Nippon Ganka Gakkai Zasshi; 1974 Feb; 78(2):93-9. PubMed ID: 4858850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
